D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 87 Citations 22,731 317 World Ranking 6850 National Ranking 3771

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Cancer

The scientist’s investigation covers issues in Internal medicine, Respiratory disease, Pathology, Cell biology and Anesthesia. His studies in Internal medicine integrate themes in fields like Gastroenterology, Endocrinology and Surgery. His research integrates issues of Pneumocystis carinii, Pneumonia and Radiology, Pulmonary hypertension, Pulmonary function testing in his study of Respiratory disease.

His Pathology research integrates issues from Central nervous system disease, Neuroscience and Lissencephaly. Jeffrey A. Golden has included themes like Apoptosis, Anatomy, Bone morphogenetic protein and Bone morphogenetic protein 2 in his Cell biology study. Jeffrey A. Golden has researched Anesthesia in several fields, including Bronchoalveolar lavage and Brain damage.

His most cited work include:

  • The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues. (1222 citations)
  • Cyclophosphamide versus placebo in scleroderma lung disease. (1084 citations)
  • Semaphorin III is needed for normal patterning and growth of nerves, bones and heart (508 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Internal medicine, Lung, Pathology, Lung transplantation and Neuroscience. His work deals with themes such as Gastroenterology, Endocrinology and Surgery, which intersect with Internal medicine. The various areas that Jeffrey A. Golden examines in his Lung study include Radiology and Immunology.

Jeffrey A. Golden studies Pathology, focusing on Pathogenesis in particular. Jeffrey A. Golden frequently studies issues relating to Cell migration and Neuroscience. His Bronchoalveolar lavage study integrates concerns from other disciplines, such as Pharmacokinetics and Pneumocystis carinii.

He most often published in these fields:

  • Internal medicine (25.00%)
  • Lung (20.00%)
  • Pathology (20.91%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (25.00%)
  • Lung (20.00%)
  • Lung transplantation (15.68%)

In recent papers he was focusing on the following fields of study:

Jeffrey A. Golden mostly deals with Internal medicine, Lung, Lung transplantation, Immunology and Idiopathic pulmonary fibrosis. His Internal medicine research includes themes of Gastroenterology, Oncology and Histopathology. His study in Lung is interdisciplinary in nature, drawing from both Biomarker, Transcriptome, Immune system and Pathology.

His work in Pathology addresses subjects such as Gene expression, which are connected to disciplines such as Allograft rejection and Downregulation and upregulation. His Lung transplantation study combines topics in areas such as Prospective cohort study, Quality of life, Lung injury and Hazard ratio. His work investigates the relationship between Idiopathic pulmonary fibrosis and topics such as FEV1/FVC ratio that intersect with problems in Exacerbation, Randomized controlled trial and Tolerability.

Between 2016 and 2021, his most popular works were:

  • The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study (102 citations)
  • Deep Learning Algorithms for Detection of Lymph Node Metastases From Breast Cancer: Helping Artificial Intelligence Be Seen. (82 citations)
  • Effect of Recombinant Human Pentraxin 2 vs Placebo on Change in Forced Vital Capacity in Patients With Idiopathic Pulmonary Fibrosis: A Randomized Clinical Trial (75 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cancer

His primary areas of investigation include Internal medicine, Lung transplantation, Prospective cohort study, Idiopathic pulmonary fibrosis and Lung. His Internal medicine study frequently draws connections between related disciplines such as Oncology. The study incorporates disciplines such as Adoptive cell transfer, Lung injury and Endogeny in addition to Lung transplantation.

His Prospective cohort study research is multidisciplinary, incorporating perspectives in Proportional hazards model and Interstitial lung disease. As a part of the same scientific family, Jeffrey A. Golden mostly works in the field of Idiopathic pulmonary fibrosis, focusing on FEV1/FVC ratio and, on occasion, Exacerbation, Tolerability and Randomized controlled trial. The Lung study which covers Cellular Ageing that intersects with Immunology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues.

Tullia Lindsten;Andrea J. Ross;Ayala King;Wei Xing Zong.
Molecular Cell (2000)

1652 Citations

Cyclophosphamide versus placebo in scleroderma lung disease.

Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Jonathan Goldin.
The New England Journal of Medicine (2006)

1501 Citations

Semaphorin III is needed for normal patterning and growth of nerves, bones and heart

Oded Behar;Jeffrey A. Golden;Hiroshi Mashimo;Frederick J. Schoen.
Nature (1996)

750 Citations

Bronchoalveolar Lavage and Transbronchial Biopsy for the Diagnosis of Pulmonary Infections in the Acquired Immunodeficiency Syndrome

C Broaddus;M D Dake;M S Stulbarg;W Blumenfeld.
Annals of Internal Medicine (1985)

530 Citations

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial

Donald P. Tashkin;Michael D. Roth;Philip J. Clements;Daniel E. Furst.
The Lancet Respiratory Medicine (2016)

528 Citations

Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease.

Donald P. Tashkin;Robert Elashoff;Philip J. Clements;Michael D. Roth.
American Journal of Respiratory and Critical Care Medicine (2007)

495 Citations

Intrapulmonary Pharmacokinetics of Linezolid

John E. Conte;Jeffrey A. Golden;Juliana Kipps;Elisabeth Zurlinden.
Antimicrobial Agents and Chemotherapy (2002)

385 Citations

Noninvasive evaluation of pulmonary artery pressure during exercise by saline-enhanced Doppler echocardiography in chronic pulmonary disease.

R B Himelman;M Stulbarg;B Kircher;E Lee.
Circulation (1989)

363 Citations

High-resolution CT diagnosis of emphysema in symptomatic patients with normal chest radiographs and isolated low diffusing capacity.

J S Klein;G Gamsu;W R Webb;J A Golden.
Radiology (1992)

305 Citations

Bronchial hyperirritability in healthy subjects after exposure to ozone

J A Golden;J A Nadel;H A Boushey.
The American review of respiratory disease (2015)

304 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jeffrey A. Golden

Andreas Strasser

Andreas Strasser

Walter and Eliza Hall Institute of Medical Research

Publications: 100

Dinesh Khanna

Dinesh Khanna

University of Michigan–Ann Arbor

Publications: 91

Daniel E. Furst

Daniel E. Furst

University of California, Los Angeles

Publications: 84

Athol U. Wells

Athol U. Wells

Imperial College London

Publications: 82

Christopher P. Denton

Christopher P. Denton

University College London

Publications: 68

David C. S. Huang

David C. S. Huang

Walter and Eliza Hall Institute of Medical Research

Publications: 58

Ganesh Raghu

Ganesh Raghu

University of Washington

Publications: 56

Luca Richeldi

Luca Richeldi

Catholic University of the Sacred Heart

Publications: 52

Vincent Cottin

Vincent Cottin

Claude Bernard University Lyon 1

Publications: 52

Jozef Gecz

Jozef Gecz

University of Adelaide

Publications: 49

Philip J. Clements

Philip J. Clements

University of California, Los Angeles

Publications: 48

William B. Dobyns

William B. Dobyns

University of Minnesota

Publications: 47

Toby M. Maher

Toby M. Maher

University of Southern California

Publications: 44

Grant Dewson

Grant Dewson

Walter and Eliza Hall Institute of Medical Research

Publications: 44

Donald P. Tashkin

Donald P. Tashkin

University of California, Los Angeles

Publications: 44

David A. Lynch

David A. Lynch

Children's Hospital of Philadelphia

Publications: 42

Trending Scientists

Min-Ling Zhang

Min-Ling Zhang

Southeast University

Tov Elperin

Tov Elperin

Ben-Gurion University of the Negev

M. Grae Worster

M. Grae Worster

University of Cambridge

Krishna R. Reddy

Krishna R. Reddy

University of Florida

David J. Sherratt

David J. Sherratt

University of Oxford

Max F. Rothschild

Max F. Rothschild

Iowa State University

Gunilla T. Westermark

Gunilla T. Westermark

Uppsala University

Antonella Sarasini

Antonella Sarasini

University of Pavia

Peter A. Hochuli

Peter A. Hochuli

University of Zurich

Sheng-Hsiang Wang

Sheng-Hsiang Wang

National Central University

Erhan Kudeki

Erhan Kudeki

University of Illinois at Urbana-Champaign

Klaus Linkenkaer-Hansen

Klaus Linkenkaer-Hansen

Vrije Universiteit Amsterdam

Keith P. W. J. McAdam

Keith P. W. J. McAdam

University of London

David C. Currow

David C. Currow

University of Technology Sydney

James C. Cox

James C. Cox

Georgia State University

J. B. Dainton

J. B. Dainton

University of Liverpool

Something went wrong. Please try again later.